A Study to Evaluate the Efficacy & Safety of QLF31907 Combination Therapy

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03671226` - Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center	N/A
Recruiting	`NCT05048160` - A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm	Phase 1/Phase 2
Active, not recruiting	`NCT03287492` - RCT of QPS vs General Information Sheet	N/A
Recruiting	`NCT01549067` - The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey	N/A
Recruiting	`NCT04119037` - Cordotomy in Reducing Pain in Patients With Advanced Cancer	N/A
Recruiting	`NCT04067336` - First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia	Phase 1/Phase 2
Recruiting	`NCT04585750` - The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)	Phase 1/Phase 2
Completed	`NCT02823652` - Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer	N/A
Completed	`NCT00244972` - Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer	Phase 1
Recruiting	`NCT06297642` - TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.	Phase 1
Active, not recruiting	`NCT01582191` - Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer	Phase 1
Active, not recruiting	`NCT03856060` - Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits	N/A
Completed	`NCT04186884` - Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings
Completed	`NCT02583269` - Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery	Phase 1
Withdrawn	`NCT03868423` - Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers	Phase 2
Terminated	`NCT02940223` - Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer	Phase 2
Active, not recruiting	`NCT01552434` - Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease	Phase 1
Active, not recruiting	`NCT03021486` - Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer	Phase 2/Phase 3
Recruiting	`NCT03203525` - Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer	Phase 1
Completed	`NCT01624766` - Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers	Phase 1

NCT number	NCT06394713
Study type	Interventional
Source	Qilu Pharmaceutical Co., Ltd.
Contact	Lin Shen
Phone	010-88196561
Email	doctorshenlin@sina.cn
Status	Not yet recruiting
Phase	Phase 1/Phase 2
Start date	June 15, 2024
Completion date	December 15, 2026

A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms